Briacell Therapeutics Corp (BCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
| 07-2025 | 07-2024 | 07-2023 | 07-2022 | 07-2021 | |
| Operating Expenses | 27,205 | 33,330 | 23,272 | 15,289 | 6,976 |
| Operating Income | -27,205 | -33,330 | -23,272 | -15,289 | -6,976 |
| Interest Expense | 0 | 0 | 0 | 1 | 79 |
| Other Income | 649 | 28,399 | 2,970 | -11,549 | -6,762 |
| Pre-tax Income | -26,556 | -4,932 | -20,302 | -26,839 | -13,816 |
| Net Income Continuous | -26,556 | -4,932 | -20,302 | -26,839 | -13,816 |
| Minority Interests | -244 | -140 | N/A | N/A | N/A |
| Net Income | $-26,312 | $-4,792 | $-20,302 | $-26,839 | $-13,816 |
| EPS Basic Total Ops | -62.19 | -43.68 | -194.90 | -259.37 | -458.77 |
| EPS Basic Continuous Ops | -62.76 | -44.96 | -194.87 | -259.70 | -458.27 |
| EPS Diluted Total Ops | -62.19 | -43.68 | -194.90 | -259.37 | -458.77 |
| EPS Diluted Continuous Ops | -62.76 | -44.96 | -194.87 | -259.70 | -458.27 |
| EPS Diluted Before Non-Recurring Items | -62.19 | -43.48 | -194.90 | -259.37 | -13.49 |
| EBITDA(a) | $-27,098 | $-33,246 | $-23,257 | $-15,274 | $-6,961 |